DNA graphic

Partners

Research Partners

The Lupus Research Alliance is proud to partner with academics, governmental agencies, and industry, committed to advancing lupus biomedical research and accelerating a cure for lupus through collaboration.

 

Lupus Industry Council

The mission of the Lupus Research Alliance Lupus Industry Council (LIC) is to bring industry and academia together in the pre-competitive space to collaboratively address common impediments and accelerate the shared goals of developing new and improved therapies for patients with lupus.

The guiding principles of the LIC are to:

  • Create opportunities for industry to come together with the Lupus Research Alliance and academia to address shared goals
  • Provide a forum for open discussion of issues related to basic/clinical research, patient care, and patient/provider education
  • Foster collaboration between industry, the Lupus Research Alliance, and academia to identify and address common challenges in basic/clinical research, patient care and patient/provider education.

LIC Projects

The following companies are currently members of the LIC:

  • AbbVie
  • Amgen
  • AstraZeneca
  • Aurinia Pharmaceuticals Inc.
  • Biogen
  • Bristol-Myers Squibb
  • Boehringer Ingelheim
  • Eli Lilly and Company
  • EMD Serono
  • Equillium, Inc.
  • GSK
  • Idorsia Pharmaceuticals
  • Janssen Research & Development, LLC
  • Pfizer Inc.
  • Sanofi
  • UCB

Corporate Leadership Circle (CLC)

Through the Corporate Leadership Circle, we hope to bring a clearer understanding of the Lupus Research Alliance’s work priorities while building an interactive dialogue with the corporate community to focus discussions on mutual goals and needs that ultimately result in more choices for treating people with lupus.

The following companies are currently members of the CLC:

  • AstraZeneca
  • Aurinia Pharmaceuticals Inc.
  • Biogen
  • Bristol Myers Squibb
  • Eli Lilly and Company
  • EMD Serono
  • GSK
  • Janssen Research & Development LLC
  • Pfizer Inc.
  • UCB
Read about the programs that support medical breakthroughs